Reliance Pharma Fund - Growth - Regular Plan

  • Previous Nav

  • Net Change on 19-07-2019

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Reliance Pharma Fund-Growth Plan-Growth 1.53 -8.52 0.72 0.58 7.54 19.07
S&P BSE Health Care 2.09 -11.80 -5.52 -7.37 1.54 13.25
S&P BSE Health Care - TRI 2.32 -11.57 -4.94 -6.85 2.10 11.56
S&P BSE SENSEX - TRI -1.71 -1.50 6.70 12.69 9.81 13.15

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Reliance Pharma Fund-Growth Plan-Growth Jun 05, 2004 Unrated 0.72 0.58 7.54 2.05 2,420.27
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 03, 1999 Unrated -1.75 -8.44 2.77 2.33 893.65
UTI Healthcare Fund - Regular Plan - Growth Option Aug 25, 1999 Unrated -4.04 -5.48 2.60 2.51 391.62

Fund Holdings as on 30-June-2019

  • Sun Pharmaceutical Industries Limited

  • Divi's Laboratories Limited

  • Cipla Limited

  • Aurobindo Pharma Limited

  • Lupin Limited

  • Syngene International Limited

  • Abbott India Limited

  • Dr. Reddy's Laboratories Limited

  • Fortis Healthcare Limited

  • Sanofi India Limited

  • Biocon Limited

  • Alkem Laboratories Limited

  • Thyrocare Technologies Limited

  • Cadila Healthcare Limited

  • Narayana Hrudayalaya Limited

  • FDC Limited

  • Indoco Remedies Limited

  • Healthcare Global Enterprises Limited

  • Triparty Repo

  • Cash Margin - Derivatives

  • Net Current Assets

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

View More

About Reliance Pharma Fund

Scheme Analysis

Reliance Pharma Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Reliance Nippon Mutual Fund. It was launched on 05-Jun-2004 and currently has an AUM of ₹2,420.27 crore. Reliance Pharma Fund is benchmarked against S&P BSE Health Care as primary index and S&P BSE Health Care - TRI as primary index and S&P BSE SENSEX - TRI as secondary index.

The NAV of Reliance Pharma Fund ended down ₹-2.11(-1.48%)yesterday to ₹140.18.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, Divi's Laboratories Limited and Cipla Limited

The Reliance Pharma Fund is managed by Sailesh Raj Bhan and Kinjal Desai.

Fund House Contact

Reliance Centre, 7th Floor, South Wing, Off Western Express Highway, Santacruz (East) Mumbai - 400 055

022-33031000
022-33037662